Additionally, CTHRC1 may serve as a sensitive predictor of the low 5-year overall survival in NSCLC and as an effective biomarker for evaluating the poor clinicopathological characteristics of NSCLC. The gene discussed is CTHRC1; the disease is non-small cell lung carcinoma.